文献速递白血病淋巴瘤

肝脏龛通过转铁蛋白-转铁蛋白受体1轴促进侵袭性自然杀伤细胞白血病增殖

The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
PubMed 文献 · Blood · 2023-01-01

研究建立3例源自侵袭性自然杀伤细胞白血病(ANKL)患者的异种移植小鼠模型(PDX),发现ANKL细胞主要在肝血窦植入并增殖,肝内ANKL细胞富集Myc通路且增殖更快;相互作用组分析和体内CRISPR-Cas9分析揭示转铁蛋白(Tf)-转铁蛋白受体1(TfR1)轴是肝脏与ANKL之间的潜在分子相互作用;ANKL细胞对铁剥夺敏感,人源化抗TfR1单克隆抗体PPMX-T003在ANKL-PDX临床前模型中显示显著疗效。

要点

  • ANKL细胞主要在肝血窦植入和增殖,肝内ANKL细胞富集Myc通路且增殖更快。
  • Tf-TfR1轴是肝脏与ANKL之间的潜在分子相互作用,ANKL细胞对铁剥夺敏感。
  • 人源化抗TfR1单克隆抗体PPMX-T003在ANKL-PDX临床前模型中显示显著治疗疗效。

核心结论

  • 肝脏作为成人非经典造血器官,是ANKL的主要龛,抑制Tf-TfR1轴是ANKL有前景的治疗策略。

研究设计与样本

  • 建立3例源自ANKL患者的异种移植小鼠模型(PDX),对肿瘤细胞及其肿瘤微环境(TME)进行分析。

主要发现

  • ANKL细胞主要在肝血窦植入和增殖,肝内ANKL细胞富集Myc通路且比其他器官的ANKL细胞增殖更快。
  • 相互作用组分析和体内CRISPR-Cas9分析揭示Tf-TfR1轴是肝脏与ANKL之间的潜在分子相互作用。
  • ANKL细胞对铁剥夺较为敏感。
  • 人源化抗TfR1单克隆抗体PPMX-T003在ANKL-PDX临床前模型中显示显著治疗疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aggressive natural killer cell leukemia (ANKL) is a rare lymphoid neoplasm frequently associated with Epstein-Barr virus, with a disastrously poor prognosis. Owing to the lack of samples from patients with ANKL and relevant murine models, comprehensive investigation of its pathogenesis including the tumor microenvironment (TME) has been hindered. Here we established 3 xenograft mice derived from patients with ANKL (PDXs), which enabled extensive analysis of tumor cells and their TME. ANKL cells primarily engrafted and proliferated in the hepatic sinusoid. Hepatic ANKL cells were characterized by an enriched Myc-pathway and proliferated faster than those in other organs. Interactome analyses and in vivo CRISPR-Cas9 analyses revealed transferrin (Tf)-transferrin receptor 1 (TfR1) axis as a potential molecular interaction between the liver and ANKL. ANKL cells were rather vulnerable to iron deprivation. PPMX-T003, a humanized anti-TfR1 monoclonal antibody, showed remarkable therapeutic efficacy in a preclinical setting using ANKL-PDXs. These findings indicate that the liver, a noncanonical hematopoietic organ in adults, serves as a principal niche for ANKL and the inhibition of the Tf-TfR1 axis is a promising therapeutic strategy for ANKL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kameda K, Yanagiya R, Miyatake Y, et al. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis. Blood. 2023. PMID: 37146246. doi:10.1182/blood.2022018597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。